The company claims its extraction process yields 175 micrograms of IGF-1 per 100 grams of material. While Insulin-like Growth Factor-1 is naturally produced in the liver to facilitate tissue development and muscle growth, Hi-Tech utilizes its patented Cyclosome® liposomal delivery system to protect the peptide. According to the manufacturer, this coating allows the compound to bypass standard digestive breakdown, reportedly increasing bioavailability by up to 1,500 percent compared to non-liposomal alternatives.
Hi-Tech Pharmaceuticals Scales Distribution of Whey-Derived IGF-1
Following a successful initial rollout, Georgia-based Hi-Tech Pharmaceuticals has entered the second phase of its nationwide distribution for PRO IGF-1®, a dietary supplement featuring Insulin-like Growth Factor-1 extracted directly from whey protein using a proprietary molecular biological technique.
Hi-Tech Pharmaceuticals, which operates four production facilities across Georgia and Pennsylvania, positions this product as a stable alternative to traditional growth hormone supplementation. The company continues to lean on its cGMP-certified infrastructure to supply various sports nutrition compounds to major national retailers. This expansion marks a shift in how the manufacturer attempts to bridge the gap between complex biochemical extraction and the broader consumer supplement market.
Comments (0)
No comments yet. Be the first!